John Mack
Mr. Mack became a member of Orchestra BioMed’s Board of Directors in July 2024.
Mr. Mack most recently served as President of Cardiac Surgery at Medtronic plc., where he successfully led the division to market leadership. During his 26-year tenure at Medtronic, he also served as Vice President & General Manager, Extracorporeal Therapies and Vice President, Business Development, Strategy & Portfolio Management where he led the business development operations for the coronary and structural heart business, a $3.2B global enterprise with over 12,000 employees. Mr. Mack has extensive board experience, including currently serving as a board member for the Minneapolis Heart Institute Foundation. Previously, Mr. Mack served on the boards of MC3 Cardiopulmonary and the Twin Cities American Heart Association.